RINT - ETF AI Analysis
Top Page
International Developed Equity Active ETF (RINT)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, indicating positive momentum.
Global Diversification Across Developed Markets
Holdings spread across countries like Japan, the U.S., the UK, France, and Germany help reduce the impact of weakness in any single market.
Leading Global Companies in Top Holdings
The fund’s largest positions include several well-known, strong-performing global firms in technology, energy, financials, and health care, which support overall returns.
Negative Factors
Moderately High Expense Ratio
The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term net returns for investors.
Concentrated Exposure to Financials and General Industries
A sizable allocation to financial and broad “general” sectors means the fund could be more sensitive if these areas face pressure.
Mixed Health Care Performance
Some major health care holdings, such as AstraZeneca, have shown weaker recent performance, which can weigh on the fund’s results if the trend continues.
RINT vs. SPDR S&P 500 ETF (SPY)
AUM158.00M
RegionDeveloped Markets
Expense Ratio0.49%
Beta0.88
IssuerRussell Investments
Inception DateMay 13, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume14,607
30 Day Avg. Volume15,158
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.80Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering327
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RINT Summary
RINT is an actively managed ETF that invests in stocks from developed countries outside the U.S., giving you broad international exposure rather than tracking a single index. It holds well-known global companies like ASML Holding and Shell, spread across many sectors such as financials, industrials, technology, and health care. An investor might consider RINT to diversify a U.S.-heavy portfolio and tap into long-term growth in markets like Japan, the UK, and Europe. A key risk is that international stock prices can be volatile and move with global markets and currencies, so the value of this ETF can go up and down.
How much will it cost me?This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with professionals selecting and adjusting the fund’s holdings instead of simply tracking an index.
What would affect this ETF?This ETF could benefit if developed markets outside the U.S. grow steadily, especially in financials, industrials, and global technology leaders like ASML and TSMC, and if international stocks come back into favor as investors look to diversify beyond the U.S. It could face challenges from global slowdowns, banking or energy sector stress, stronger regulations or taxes in Europe and other regions, or rising interest rates that hurt stock prices in its major markets.
RINT Top 10 Holdings
RINT leans heavily into non-U.S. blue chips, with a clear tilt toward global semis and healthcare. ASML and TSMC have been key engines for the fund this year, even if they’ve cooled off lately, while European energy giant Shell and banks like HSBC and UBS are steadily pulling their weight. The real soft spot has been AstraZeneca, which has been losing steam and dampening healthcare’s otherwise solid showing, partly offset by rising names like Roche and Novartis. Overall, performance is driven by a diversified mix across developed markets outside the U.S.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.77% | $3.86M | €572.06B | 126.61% | 76 Outperform | |
| TSMC | 1.65% | $2.30M | $1.98T | 79.33% | 81 Outperform | |
| UBS Group AG | 1.32% | $1.84M | $165.25B | 33.89% | 73 Outperform | |
| HSBC Holdings | 1.15% | $1.60M | £261.36B | 57.36% | 80 Outperform | |
| Tokyo Electron | 1.05% | $1.47M | ¥25.23T | 150.60% | 73 Outperform | |
| Schneider Electric | 0.97% | $1.35M | €168.96B | 39.29% | 62 Neutral | |
| Shell (UK) | 0.96% | $1.34M | £185.88B | 21.93% | 73 Outperform | |
| Roche Holding AG | 0.93% | $1.30M | $365.11B | 43.45% | 73 Outperform | |
| AstraZeneca | 0.89% | $1.24M | $257.86B | 2.57% | 80 Outperform | |
| GlaxoSmithKline | 0.87% | $1.21M | £76.11B | 26.89% | 77 Outperform |
RINT Technical Analysis
Positive
―
Price Trends
32.38
Positive
31.77
Positive
30.67
Positive
Market Momentum
0.26
Positive
57.61
Neutral
27.00
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RINT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.08, equal to the 50-day MA of 32.38, and equal to the 200-day MA of 30.67, indicating a bullish trend. The MACD of 0.26 indicates Positive momentum. The RSI at 57.61 is Neutral, neither overbought nor oversold. The STOCH value of 27.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RINT.
RINT Peer Comparison
Comparison Results
Performance Comparison
RINT
International Developed Equity Active ETF
33.18
6.04
22.25%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
NBIE
Neuberger International Core Equity ETF
―
―
―
DXIV
Dimensional International Vector Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents